Fillit H M, Futterman R, Orland B I, Chim T, Susnow L, Picariello G P, Scheye E C, Spoeri R K, Roglieri J L, Warburton S W
Institute for the Study of Aging, New York, NY 10153, USA.
Am J Manag Care. 1999 May;5(5):587-94.
To examine the effects of medication reviews by primary care physicians on prescriptions written for elderly members of a Medicare managed care organization who were at risk for polypharmacy.
Prospective study with follow-up survey.
We conducted a study in 1995 to demonstrate the prevalence of polypharmacy (defined as receiving 5 or more prescription medications during the 3-month study period) among elderly members of our managed care organization. Two years later, elderly members identified as being at risk for polypharmacy were sent a letter encouraging them to schedule a medication review with their primary care physician. Each primary care physician was provided with clinical practice guidelines on polypharmacy and patient-specific medication management reports. Patients and physicians were subsequently mailed a survey to assess the impact of the medication review program on prescribing practices.
Of 37,372 elderly members screened, 5737 (15%) were at risk for polypharmacy. Of these, 2615 (46%) responded to the follow-up survey. Of the survey respondents, 1087 (42%) had gone to their primary care physician for a medication review. During the review, 96% of patients discussed their prescription medications and 72% discussed nonprescription medications they were taking. Twenty percent reported that their physician discontinued medications, 29% reported that the physician changed the dose of a medication, and 17% informed their physician about a new prescription or nonprescription medication they were taking. Of the 275 primary care physicians surveyed, 56 (20%) returned the questionnaire. Of these, 61% reported that the medication review program was "very" or "somewhat useful." Thirty-five percent reported discontinuing unnecessary medications, and 23% reported decreasing the frequency of dosing. Overall, 45% of physicians reported making at least one change in their prescribing to a member at risk for polypharmacy.
Our program promoting medication reviews between primary care physicians and their elderly patients resulted in significant changes in prescribing by physicians. This type of program is likely to decrease the risk of polypharmacy among older members of a Medicare managed care organization.
探讨初级保健医生进行药物评估对为患有多重用药风险的医疗保险管理式医疗组织老年成员所开具处方的影响。
前瞻性研究及随访调查。
我们在1995年开展了一项研究,以证明我们管理式医疗组织老年成员中多重用药(定义为在3个月研究期间接受5种或更多处方药治疗)的患病率。两年后,被确定有多重用药风险的老年成员收到一封信,鼓励他们安排与初级保健医生进行药物评估。为每位初级保健医生提供了关于多重用药的临床实践指南和针对患者的药物管理报告。随后向患者和医生邮寄了一份调查问卷,以评估药物评估项目对处方开具行为的影响。
在筛查的37372名老年成员中,5737名(15%)有多重用药风险。其中,2615名(46%)回复了随访调查。在调查对象中,1087名(42%)前往初级保健医生处进行药物评估。在评估过程中,96%的患者讨论了他们的处方药,72%的患者讨论了他们正在服用的非处方药。20%的患者报告医生停用了药物,29%的患者报告医生改变了药物剂量,17%的患者告知医生他们正在服用的新处方药或非处方药。在接受调查的275名初级保健医生中,56名(20%)回复了问卷。其中,61%的医生报告药物评估项目“非常”或“有些有用”。35%的医生报告停用了不必要的药物,23%的医生报告减少了给药频率。总体而言,45%的医生报告至少对有多重用药风险的成员的处方做了一处更改。
我们促进初级保健医生与其老年患者之间进行药物评估的项目,使医生的处方开具行为发生了显著变化。这类项目可能会降低医疗保险管理式医疗组织老年成员多重用药的风险。